Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemo-radiotherapy in PET stage II and III Merkel cell carcinoma
NCT01013779Phase 2Completed
- Sponsor
- Trans-Tasman Radiation Oncology Group
- Start
- Dec 2009
- Primary completion
- Jun 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, etoposide in Merkel cell carcinoma (MCC), sponsored by Trans-Tasman Radiation Oncology Group. Started Dec 2009; status: completed.
02
Drugs
carboplatinetoposide
03
Conditions
Merkel cell carcinoma (MCC)
Beyond the preview
Go deeper on NCT01013779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01013779.